page 5 - A global healthcare leader
As a healthcare company with a diversified portfolio, an extensive geographic presence and a large number of employees, sanofi-aventis has important economic, social and environmental responsibilities to its stakeholders.
- • Approximately 105,000 employees in 110 countries
- • A diversifi ed product portfolio with prescription drugs, consumer healthcare products (OTC) and generics
- • N° 1 in emerging markets(1) with a balanced and long-established presence
- • A global leader in human vaccines
- • A global leader in animal health
- • 2009 sales: 29.3 billion euros, with growth of 6.3%(2)
- • 33 acquisitions and partnerships in 2009
(1) Worldwide excluding the United States, Canada, Western Europe (France, Germany, United Kingdom, Italy, Spain, Greece, Cyprus, Malta, Belgium, Luxemburg, Sweden, Portugal, the Netherlands, Austria, Switzerland, Ireland, Finland, Norway, Iceland, Denmark), Japan, Australia and New Zealand.
(2) Compared to 2008 published data.
Sanofi-aventis’ ambition is to become a diversified global healthcare company focused on the patient’s needs.
To reach this objective and deliver sustainable growth, the Group is focusing on three key themes:
- • Increasing innovation in Research and Development;
- • Seizing external growth opportunities
- • Adapting Group structures to meet future challenges.
Sanofi-aventis relies on its core strengths in the healthcare field, with five key platforms for growth:
- • Emerging markets
- • Vaccines
- • Consumer healthcare products
- • The diabetes drugs portfolio
- • Innovative products.